Pharmacological treatment & current controversies in COPD

Mario Cazzola (Italy)

Source: ERS Course 2019 - Masterclass in airways disease 2019
Number: 10
Disease area: Airway diseases

Slide presentationPDF journal article, handout or slidesWebcast

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mario Cazzola (Italy). Pharmacological treatment & current controversies in COPD. ERS Course 2019 - Masterclass in airways disease 2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Privilage Masoni - 06.10.2019 07:01
Excellent , thought-provoking lecture.
You must Login to comment this presentation.


Related content which might interest you:
Pharmacological treatment & current controversies in asthma
Source: ERS Course 2019 - Masterclass in airways disease 2019
Year: 2019


Current opinion: Pharmacological approaches in asthma and COPD
Source: Breathe 2009; 6: 24-35
Year: 2009

Pharmacological options for the treatment of COPD: present and future
Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy
Year: 2007

Treatment of COPD: from pharmacological to instrumental therapies
Source: Eur Respir Rev 2009; 19: 7-23
Year: 2010


Recommendations for pharmacological treatment of exacerbations of COPD
Source: International Congress 2017 – Treatment and prevention of COPD exacerbation
Year: 2017


COPD - Current challenges
Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge
Year: 2008


Prescription opioid use in advanced COPD: benefits, perils and controversies
Source: Eur Respir J, 49 (6) 1700690; 10.1183/13993003.00690-2017
Year: 2017



Prescription opioid use in advanced COPD: benefits, perils and controversies
Source: Eur Respir J, 49 (6) 1700479; 10.1183/13993003.00479-2017
Year: 2017



Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence
Source: Eur Respir Rev, 27 (150) 180074; 10.1183/16000617.0074-2018
Year: 2018



What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement
Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018
Year: 2018



Current controversies in the treatment of COPD
Source: Annual Congress 2011 - Lancet / ERS symposium - New frontiers in COPD
Year: 2011

Prevention of COPD exacerbations: medications and other controversies
Source: ERJ Open Res 2015; 1: 00011-2015
Year: 2015



What is the scientific and clinical rationale? Triple therapy in COPD patients
Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what?
Year: 2021


Rational monitoring of COPD: where do current clinical guidelines stand?
Source: Eur Respir J 2007; 29: 1078-1081
Year: 2007


Some advances in COPD treatment and management
Source: Eur Respir J 2004; 24: Suppl. 48, 85s
Year: 2004

Dose-FEV1 modeling to support future development of AZD2115, a dual acting bronchodilator for the treatment of COPD
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015